1887

Abstract

SUMMARY

The activities of azlocillin and ticarcillin against were compared by estimating minimum inhibitory and bactericidal concentrations (MIC and MBC) in liquid and solid media, and by constructing killing curves from sequential viable counts. In MIC studies, azlocillin was about three times more active than ticarcillin in solid medium (agar dilution test) and in liquid media (tube and microdilution tests). When the MBC was measured, however, results varied according to the technique used. On agar and in microdilution tests, both azlocillin and ticarcillin were bactericidal, the MBC being 1.3-3 MIC. In the tube test, the MBC for ticarcillin was again about 3 MIC, but azlocillin appeared not to be bactericidal (MBC < 1 mg/ml). However, sequential viable counts of four clinical isolates showed that at 4 MIC both antibiotics reduced viable counts by a factor of 10 in 8 h. Our results stress the importance of methodology when assessing the antibacterial activity of an antibiotic.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-17-1-37
1984-02-01
2022-08-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/17/1/medmicro-17-1-37.html?itemId=/content/journal/jmm/10.1099/00222615-17-1-37&mimeType=html&fmt=ahah

References

  1. Basker M. J., Edmondson R. A. E., Sutherland R. 1979; Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of Pseudomonas aeruginosa and Klebsiella aerogenes. Infection 7:67–73
    [Google Scholar]
  2. Batchelor F. R., Chain E. B., Hardy T. L., Mansford K. R. L., Rolinson G. N. 1961; 6-aminopenicillanic acid. III. Isolation and purification. Proceedings of the Royal Society B 154:498–508
    [Google Scholar]
  3. Brown D., Blowers R. 1978; Disc methods of sensitivity testing and other semiquantitative methods. In Reeves D. S., Phillips I, Williams J. D., Wise R. (eds) Laboratory Methods in Antimicrobial Chemotherapy Churchill Livingstone; Edinburgh: pp 8–30
    [Google Scholar]
  4. Cruickshank R., Duguid J. P., Swain R. H. A. 1969; Medical Microbiology. 11th edn E. & S. Livingstone; Edinburgh: p 901
    [Google Scholar]
  5. Curtis N. A. C. 1981; Penicillin-binding proteins in theory and practice. Journal of Antimicrobial Chemotherapy 8:85–87
    [Google Scholar]
  6. Curtis N. A. C., Orr D., Ross G. W., Boulton M. G. 1979; Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K12 and their antibacterial activity. Antimicrobial Agents and Chemotherapy 15:533–539
    [Google Scholar]
  7. EORTC International Antimicrobial Therapy Project Group 1978; Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 137:14–29
    [Google Scholar]
  8. Fass R. J. 1982; Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test. Antimicrobial Agents and Chemotherapy 22:28–31
    [Google Scholar]
  9. Fu K. P., Neu H. C. 1978; Azlocillin and mezlocillin: new ureido penicillins. Antimicrobial Agents and Chemotherapy 13:930–938
    [Google Scholar]
  10. Furth A. 1979; The β-lactamases of Pseudomonas aeruginosa. In Hamilton-Miller J. M. T., Smith J. T. (eds) Beta-lactamases Academic Press; London: pp 403–428
    [Google Scholar]
  11. Greenwood D., Eley A. 1982; A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal β-lactam antibiotics. Journal of Infectious Diseases 145:110–117
    [Google Scholar]
  12. Gwynn M. N., Rolinson G. N. 1980; Selection of variants of Pseudomonas aeruginosa resistant to beta-lactam antibiotics. Infection 8:73–80
    [Google Scholar]
  13. Gwynn M. N., Webb L. T., Rolinson G. N. 1981; Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other β-lactam antibiotics. Journal of Infectious Diseases 144:263–269
    [Google Scholar]
  14. Kurtz S., Holmes K., Turck M. 1975; Disparity between inhibitory and killing effects of BL-P1654 Antimicrobial Agents and Chemotherapy. 7:215–218
    [Google Scholar]
  15. Labia R., Beguin R., Masson J. M., Kazmierczak A. 1982; Cefsulodin and Pseudomonas aeruginosa: the influence of β-lactamases. In Periti P, Grassi G. G. (eds) Current chemotherapy and immunotherapy, 1. American Society of Microbiology Washington: pp 511–513
    [Google Scholar]
  16. O’Grady F. (editor) 1978; Ticarcillin (BRL 2288). Proceedings of an international symposium. Excerpta Medica, Amsterdam, International Congress Series. no 445
    [Google Scholar]
  17. Phaneuf D., Neu H. C. 1979; Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin and ticarcillin. Antimicrobial Agents and Chemotherapy 16:625–630
    [Google Scholar]
  18. Ryan D. M., Monsey D. 1981; Bacterial filamentation and in-vivo efficacy: a comparison of several cephalosporins. Journal of Antimicrobial Chemotherapy 7:57–63
    [Google Scholar]
  19. Shah P. P., Briedis D. J., Robson H. G., Conterato J. P. 1979; In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 15:346–350
    [Google Scholar]
  20. Siegenthaler W., Weuta H. (eds) 1980; Acylureidopenicillins. Proceedings of an international symposium. Excerpta Medica Amsterdam:
    [Google Scholar]
  21. White A. R., Comber K. R., Sutherland R. 1980; Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 18:182–189
    [Google Scholar]
  22. Wirth K., Schomerus M., Hengstmann J. H. 1976; Zur Pharmakokinetik von Azlocillin, einem neuen halbsynthetischen Breitspektrumantibiotikum Infection. 4:25–30
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-17-1-37
Loading
/content/journal/jmm/10.1099/00222615-17-1-37
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error